Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.84−0.07 (-3.66%)
Close on Nov 13, 2026Market cap $2.92MP/E –Yield –
Silo Pharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Silo Pharma's profit margin for the twelve months ending Sep 30, 2026 was -10319.0%. For fiscal 2025 it was -5863.5%, against -6092.6% the year before. The highest annual figure on record is -2497.7% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -5863.5% | +229.1 |
| FY2024 | Dec 31, 2024 | -6092.6% | −960.0 |
| FY2023 | Dec 31, 2023 | -5132.6% | +288.3 |
| FY2022 | Dec 31, 2022 | -5420.9% | +2001.7 |
| FY2020 | Dec 31, 2020 | -7422.5% | −4924.8 |
| FY2019 | Dec 31, 2019 | -2497.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -9137.5% | −3415.5 |
| Q4 FY2025 | Dec 31, 2025 | -4890.3% | +4710.4 |
| Q3 FY2025 | Sep 30, 2025 | -6160.5% | −1007.6 |
| Q2 FY2025 | Jun 30, 2025 | -6681.2% | −461.5 |
| Q1 FY2025 | Mar 31, 2025 | -5721.9% | −398.0 |
| Q4 FY2024 | Dec 31, 2024 | -9600.7% | −376.1 |
| Q3 FY2024 | Sep 30, 2024 | -5152.9% | +302.0 |
| Q4 FY2023 | Dec 31, 2023 | -6219.8% | −2567.1 |
| Q1 FY2023 | Jun 30, 2023 | -5324.0% | −4645.4 |
| Q4 FY2022 | Dec 31, 2022 | -9224.6% | −7262.5 |
| Q3 FY2022 | Sep 30, 2022 | -5454.9% | −1885.6 |
| Q2 FY2022 | Jun 30, 2022 | -3652.7% | +239.2 |
| Q2 FY2021 | Jun 30, 2021 | -678.5% | +61371.6 |
| Q1 FY2021 | Mar 31, 2021 | -1962.1% | +79288.5 |
| Q4 FY2020 | Dec 31, 2020 | -3569.3% | −2621.2 |
| Q3 FY2020 | Sep 30, 2020 | -3891.9% | +95168.2 |
| Q2 FY2020 | Jun 30, 2020 | -62050.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -81250.7% | – |
| Q4 FY2019 | Dec 31, 2019 | -948.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -99060.1% | – |
See a number that looks wrong?